Metabolic And Bariatric Surgery And Obesity Pharmacotherapy For Cancer Prevention: Current Status And Future Possibilities

Document Type

Article

Publication Date

5-4-2023

Publication Title

Journal of the National Cancer Institute. Monographs

Abstract

Obesity is a chronic, relapsing, progressive disease of excess adiposity that increases the risk of developing at least 13 types of cancer. This report provides a concise review of the current state of the science regarding metabolic and bariatric surgery and obesity pharmacotherapy related to cancer risk. Meta-analyses of cohort studies report that metabolic and bariatric surgery is independently associated with a lower risk of incident cancer than nonsurgical obesity care. Less is known regarding the cancer-preventive effects of obesity pharmacotherapy. The recent approval and promising pipeline of obesity drugs will provide the opportunity to understand the potential for obesity therapy to emerge as an evidence-based cancer prevention strategy. There are myriad research opportunities to advance our understanding of how metabolic and bariatric surgery and obesity pharmacotherapy may be used for cancer prevention.

First Page

68

Last Page

76

PubMed ID

37139980

Volume

2023

Issue

61

Link to Full Text

Share

COinS